Click for best price
Lung Cancer Diagnostics Market Size, Share 2022
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
This report contains market size and forecasts of Lung Cancer Diagnostics in Global, including the following market information:
Global top five companies in 2021 (%)
The global Lung Cancer Diagnostics market was valued at 1938 million in 2021 and is projected to reach US$ 2805.4 million by 2028, at a CAGR of 5.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunoassays Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Diagnostics include Roche Diagnostics, BioM?rieux, Qiagen, Advpharma, AIT Austrian Institute of Technology, Courtagen Life Sciences, DiagnoCure, BioMark Diagnostics and Mayo Clinic and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
- Immunoassays
- Flow Cytometry
- Rapid Tests
- Molecular Assays
- Tissue Arrays
- Circulating Tumor Cells
- Pharmacodiagnostics
- Biomarkers
- Other
Global Lung Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
- Industrial
- Healthcare
- Other
Global Lung Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lung Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Lung Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Lung Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche Diagnostics
- BioM?rieux
- Qiagen
- Advpharma
- AIT Austrian Institute of Technology
- Courtagen Life Sciences
- DiagnoCure
- BioMark Diagnostics
- Mayo Clinic
- HalioDx SAS
| Report Attributes |
Report Details |
| Report Title |
Lung Cancer Diagnostics Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Diagnostics Overall Market Size
2.1 Global Lung Cancer Diagnostics Market Size: 2021 VS 2028
2.2 Global Lung Cancer Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Diagnostics Players in Global Market
3.2 Top Global Lung Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Lung Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lung Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Lung Cancer Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Immunoassays
4.1.3 Flow Cytometry
4.1.4 Rapid Tests
4.1.5 Molecular Assays
4.1.6 Tissue Arrays
4.1.7 Circulating Tumor Cells
4.1.8 Pharmacodiagnostics
4.1.9 Biomarkers
4.1.10 Other
4.2 By Type - Global Lung Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Lung Cancer Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Lung Cancer Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Diagnostics Market Size, 2021 & 2028
5.1.2 Industrial
5.1.3 Healthcare
5.1.4 Other
5.2 By Application - Global Lung Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Lung Cancer Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Lung Cancer Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Lung Cancer Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Lung Cancer Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Lung Cancer Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Lung Cancer Diagnostics Revenue, 2017-2028
6.3.2 US Lung Cancer Diagnostics Market Size, 2017-2028
6.3.3 Canada Lung Cancer Diagnostics Market Size, 2017-2028
6.3.4 Mexico Lung Cancer Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Diagnostics Revenue, 2017-2028
6.4.2 Germany Lung Cancer Diagnostics Market Size, 2017-2028
6.4.3 France Lung Cancer Diagnostics Market Size, 2017-2028
6.4.4 U.K. Lung Cancer Diagnostics Market Size, 2017-2028
6.4.5 Italy Lung Cancer Diagnostics Market Size, 2017-2028
6.4.6 Russia Lung Cancer Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Lung Cancer Diagnostics Market Size, 2017-2028
6.4.8 Benelux Lung Cancer Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Diagnostics Revenue, 2017-2028
6.5.2 China Lung Cancer Diagnostics Market Size, 2017-2028
6.5.3 Japan Lung Cancer Diagnostics Market Size, 2017-2028
6.5.4 South Korea Lung Cancer Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Lung Cancer Diagnostics Market Size, 2017-2028
6.5.6 India Lung Cancer Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Lung Cancer Diagnostics Revenue, 2017-2028
6.6.2 Brazil Lung Cancer Diagnostics Market Size, 2017-2028
6.6.3 Argentina Lung Cancer Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Diagnostics Revenue, 2017-2028
6.7.2 Turkey Lung Cancer Diagnostics Market Size, 2017-2028
6.7.3 Israel Lung Cancer Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Lung Cancer Diagnostics Market Size, 2017-2028
6.7.5 UAE Lung Cancer Diagnostics Market Size, 2017-2028
7 Players Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Corporate Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Lung Cancer Diagnostics Major Product Offerings
7.1.4 Roche Diagnostics Lung Cancer Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Roche Diagnostics Key News
7.2 BioM?rieux
7.2.1 BioM?rieux Corporate Summary
7.2.2 BioM?rieux Business Overview
7.2.3 BioM?rieux Lung Cancer Diagnostics Major Product Offerings
7.2.4 BioM?rieux Lung Cancer Diagnostics Revenue in Global Market (2017-2022)
7.2.5 BioM?rieux Key News
7.3 Qiagen
7.3.1 Qiagen Corporate Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Lung Cancer Diagnostics Major Product Offerings
7.3.4 Qiagen Lung Cancer Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Qiagen Key News
7.4 Advpharma
7.4.1 Advpharma Corporate Summary
7.4.2 Advpharma Business Overview
7.4.3 Advpharma Lung Cancer Diagnostics Major Product Offerings
7.4.4 Advpharma Lung Cancer Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Advpharma Key News
7.5 AIT Austrian Institute of Technology
7.5.1 AIT Austrian Institute of Technology Corporate Summary
7.5.2 AIT Austrian Institute of Technology Business Overview
7.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Major Product Offerings
7.5.4 AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue in Global Market (2017-2022)
7.5.5 AIT Austrian Institute of Technology Key News
7.6 Courtagen Life Sciences
7.6.1 Courtagen Life Sciences Corporate Summary
7.6.2 Courtagen Life Sciences Business Overview
7.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Major Product Offerings
7.6.4 Courtagen Life Sciences Lung Cancer Diagnostics Revenue in Global Market (2017-2022)
7.6.5 Courtagen Life Sciences Key News
7.7 DiagnoCure
7.7.1 DiagnoCure Corporate Summary
7.7.2 DiagnoCure Business Overview
7.7.3 DiagnoCure Lung Cancer Diagnostics Major Product Offerings
7.7.4 DiagnoCure Lung Cancer Diagnostics Revenue in Global Market (2017-2022)
7.7.5 DiagnoCure Key News
7.8 BioMark Diagnostics
7.8.1 BioMark Diagnostics Corporate Summary
7.8.2 BioMark Diagnostics Business Overview
7.8.3 BioMark Diagnostics Lung Cancer Diagnostics Major Product Offerings
7.8.4 BioMark Diagnostics Lung Cancer Diagnostics Revenue in Global Market (2017-2022)
7.8.5 BioMark Diagnostics Key News
7.9 Mayo Clinic
7.9.1 Mayo Clinic Corporate Summary
7.9.2 Mayo Clinic Business Overview
7.9.3 Mayo Clinic Lung Cancer Diagnostics Major Product Offerings
7.9.4 Mayo Clinic Lung Cancer Diagnostics Revenue in Global Market (2017-2022)
7.9.5 Mayo Clinic Key News
7.10 HalioDx SAS
7.10.1 HalioDx SAS Corporate Summary
7.10.2 HalioDx SAS Business Overview
7.10.3 HalioDx SAS Lung Cancer Diagnostics Major Product Offerings
7.10.4 HalioDx SAS Lung Cancer Diagnostics Revenue in Global Market (2017-2022)
7.10.5 HalioDx SAS Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lung Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Diagnostics Market Drivers in Global Market
Table 3. Lung Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Diagnostics in Global Market
Table 5. Top Lung Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lung Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lung Cancer Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lung Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Lung Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Lung Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lung Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lung Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Lung Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lung Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lung Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Lung Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lung Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lung Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lung Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lung Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lung Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lung Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lung Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Roche Diagnostics Corporate Summary
Table 31. Roche Diagnostics Lung Cancer Diagnostics Product Offerings
Table 32. Roche Diagnostics Lung Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. BioM?rieux Corporate Summary
Table 34. BioM?rieux Lung Cancer Diagnostics Product Offerings
Table 35. BioM?rieux Lung Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Qiagen Corporate Summary
Table 37. Qiagen Lung Cancer Diagnostics Product Offerings
Table 38. Qiagen Lung Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Advpharma Corporate Summary
Table 40. Advpharma Lung Cancer Diagnostics Product Offerings
Table 41. Advpharma Lung Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. AIT Austrian Institute of Technology Corporate Summary
Table 43. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Offerings
Table 44. AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Courtagen Life Sciences Corporate Summary
Table 46. Courtagen Life Sciences Lung Cancer Diagnostics Product Offerings
Table 47. Courtagen Life Sciences Lung Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. DiagnoCure Corporate Summary
Table 49. DiagnoCure Lung Cancer Diagnostics Product Offerings
Table 50. DiagnoCure Lung Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. BioMark Diagnostics Corporate Summary
Table 52. BioMark Diagnostics Lung Cancer Diagnostics Product Offerings
Table 53. BioMark Diagnostics Lung Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Mayo Clinic Corporate Summary
Table 55. Mayo Clinic Lung Cancer Diagnostics Product Offerings
Table 56. Mayo Clinic Lung Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. HalioDx SAS Corporate Summary
Table 58. HalioDx SAS Lung Cancer Diagnostics Product Offerings
Table 59. HalioDx SAS Lung Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Lung Cancer Diagnostics Segment by Type in 2021
Figure 2. Lung Cancer Diagnostics Segment by Application in 2021
Figure 3. Global Lung Cancer Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lung Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Diagnostics Revenue in 2021
Figure 8. By Type - Global Lung Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lung Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lung Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lung Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lung Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lung Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lung Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lung Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lung Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Diagnostics Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioM?rieux Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Qiagen Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Advpharma Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Courtagen Life Sciences Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. DiagnoCure Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BioMark Diagnostics Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mayo Clinic Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. HalioDx SAS Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
